PMCB holders · CITADEL ADVISORS LLC 13F · PMCB stock
CITADEL ADVISORS LLC PharmaCyte Biotech Inc (PMCB) 13F holding
CITADEL ADVISORS LLC reported 359,547 PMCB shares valued at $239.2K as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.
This is the newest PMCB 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the PMCB holders table.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 359,547 | $239.2K | COM NEW |
| 2025-12-31 | 229,722 | $166.3K | COM NEW |
| 2025-09-30 | 14,531 | $14.1K | COM NEW |
Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.